SCLERODERMA
Clinical trials for SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA trials appear
Sign up with your email to follow new studies for SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for scleroderma patients with lung damage
Disease control CompletedThis completed Phase 3 trial tested whether adding intravenous cyclophosphamide to standard prednisone treatment could better stabilize or improve lung function in people with scleroderma-related lung scarring. The study involved 40 adults whose lung function had recently worsene…
Matched conditions: SCLERODERMA
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Radical reset vs. standard drugs: the fight to control a severe autoimmune disease
Disease control CompletedThis study aimed to find the best initial treatment for people recently diagnosed with a severe, fast-moving form of scleroderma. It compared two approaches: an aggressive stem cell transplant right away versus starting with standard immunosuppressive drugs and saving the transpl…
Matched conditions: SCLERODERMA
Phase: PHASE4 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New scan seeks safer way to track deadly lung scarring
Diagnosis CompletedThis study tested whether a special type of MRI scan could be used to measure lung scarring (fibrosis) in people with scleroderma. Researchers wanted to see if this method, which doesn't use radiation, could be a better and more reproducible way to track the disease compared to c…
Matched conditions: SCLERODERMA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Apr 01, 2026 14:41 UTC
-
Online support groups aim to empower scleroderma patients
Symptom relief CompletedThis study tested an online program designed to help people with scleroderma (systemic sclerosis) better manage their symptoms and daily life. The program included educational videos and group video sessions led by trained peers. Researchers compared the program to usual care to …
Matched conditions: SCLERODERMA
Phase: NA • Sponsor: Lady Davis Institute • Aim: Symptom relief
Last updated Apr 04, 2026 00:06 UTC
-
Could simple yoga ease the burden of a rare disease?
Symptom relief CompletedThis small, completed pilot study explored whether gentle yoga and breathing exercises could help people with scleroderma manage their symptoms and improve their quality of life. Thirty participants learned the exercises and practiced them at home twice daily for 12 weeks while r…
Matched conditions: SCLERODERMA
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
Researchers probe hormone link to Hard-to-Treat autoimmune disease
Knowledge-focused CompletedThis study aimed to understand if a hormone called prolactin is involved in systemic scleroderma, a disease that causes hardening of the skin and internal organs. Researchers measured prolactin levels in 71 adults with scleroderma and compared them to healthy people. The goal was…
Matched conditions: SCLERODERMA
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:05 UTC
-
Does question order skew depression scores in chronic illness?
Knowledge-focused CompletedThis study investigated whether the order of questions in a standard depression survey affects how people with scleroderma (systemic sclerosis) report physical symptoms like fatigue and sleep problems. Researchers wanted to know if patients score these symptoms differently when t…
Matched conditions: SCLERODERMA
Phase: NA • Sponsor: Lady Davis Institute • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC
-
Scientists probe why scleroderma Patients' hearts fail
Knowledge-focused CompletedThis research study aims to understand why people with scleroderma and pulmonary hypertension develop heart muscle weakness. Researchers will compare heart function and collect tissue samples from 43 participants during their standard medical procedures. The goal is to identify d…
Matched conditions: SCLERODERMA
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC